CDER biosimilars director Christl to leave FDA

Leah Christl will step down on Feb. 22 as director of the Therapeutic Biologics and Biosimilars Staff Center within FDA's Center for Drug Evaluation and Research (CDER).

Christl, who joined FDA in 2003, is leaving to pursue other opportunities...